United Kingdom
Medizinprodukt-Marktintelligenz für United Kingdom. Regulatorische Änderungen, Wettbewerber und Beschaffungstrends.
Länder-Tabelle zuletzt: 9. Aug. 2026 (kann veraltet sein). 7-Tage-Zahl ist live neu berechnet. Tabellenwert war 275.
Signale der letzten 7 Tage
Argenx cans Phase III Vyvgart Sjögren’s study on predicted efficacy fail
MimiVax announces disappointing pivotal Phase IIb trial data for cancer vaccine
BMS’s Zenbexus meets PFS endpoint in pivotal multiple myeloma trial
Alzheimer’s disease market expected to reach $14.7bn across the 8MM by 2033
Ebola: Kenya marks first case and fatality in Bundibugyo strain outbreak
Argus Cognitive’s paediatric autism diagnostic secures FDA clearance
Author Correction: Natural killer T cells and CD8+ T cells are dispensable for T cell–dependent allergic airway inflammation
£33.2m to protect public from future epidemics and pandemics
This year’s Nobel science prizes are real-life sci-fi
I’m a personal trainer and this compact dumbbell set is the best additon to my home gym
Guidance: Pneumococcal Vaccine Factsheet – Information for Patients, Parents and Carers
'Ominous signs' of winter pressures as NHS waiting list grows
10x Genomics and Fred Hutch partner on cancer technologies
Podcast: Key takeaways from EASD 2026 on where GLP-1s are headed
CPHI 2026: Finding the right CDMO partner in an age of consolidation
FDA approves Pfizer’s Tukysa regimen for metastatic breast cancer
Change lifestyle before giving children weight loss medication, WHO says
David Oliver: Thirlwall has highlighted that NHS managers still face no statutory, regulated duty of candour and transparency
Community hospitals provide an important alternative to direct discharge
Galleri: Trial results show why the NHS must not follow the US FDA in approving the multicancer test